Skip to main content

Table 1 Clinical features of the subjects included in the study

From: Polymorphism in asparagine synthetase is associated with overall survival of hepatocellular carcinoma patients

A. Realtime PCR Study

 

Non-HBV controls n = 70

CHB patients n = 77

HCC patients n = 90

Age, y mean ± SD

48.2 ± 7.5

49.1 ± 10.1

50.3 ± 9.5

Gender, n. (%)

 Male

39(55.7)

43(55.8)

50(55.6)

 Famale

31(44.3)

34(44.2)

40(44.4)

Smoking, n. (%)

 Yes

30(42.9)

45(58.4)

55(61.1)

 No

40(57.1)

32(41.6)

35(38.9)

Drinking, n. (%)

 Yes

33(47.1)

50(64.9)

73(81.1)

 No

37(52.9)

27(35.1)

17(18.9)

B. Case–control Study

 

HCC

CHB

P

Number

337

310

 

Age, y mean ± SD

44.7 ± 11.0

44.3 ± 12.3

0.67

Gender (male/female)

298/39

254/56

0.02

Smoking (Yes/No)

141/192

128/182

0.79

Drinking (Yes/No)

98/239

92/218

0.87

Family history of HCC (Yes/No)

58/279

14/296

<0.001

  1. HCC hepatocellular carcinoma, CHB chronic hepatitis B